Monday, May 28, 2018
Tags Roche

Tag: Roche

Roche Breast Cancer Drug Treatment Time Can Be Halved – Study

By Deena Beasley (Reuters) Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, researchers...

High-Flying Biotech Loxo Tempers Bullish View for Cancer Drug

By Bill Berkrot STAMFORD, Connecticut (Reuters) In record time, Loxo Oncology developed a novel drug for a wide variety of tumors that share a rare mutation....

Singapore Pharma on Recovery Path after Worst Output in Decades

By Masayuki Kitano and John Geddie SINGAPORE (Reuters) Singapore's pharmaceuticals business, among the pillars of the city-state's manufacturing sector, is set to return to strength this...

Roche’s Tecentriq Cocktail Adds to Lung Cancer Survival Success

ZURICH (Reuters) Roche's Tecentriq immunotherapy combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss company said as it seeks...

Roche’s Tecentriq Notches Third Cancer Cocktail Trial Win

By John Miller ZURICH (Reuters) Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for...

Big Pharma, Big Data: Why Drugmakers Want Your Health Records

By Ben Hirschler LONDON (Reuters) Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start...
banner